BSE Live
Sep 05, 16:01Prev. Close
929.40
Open Price
945.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 05, 15:59Prev. Close
929.10
Open Price
931.50
Bid Price (Qty.)
923.00 (3)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Alivus Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 24.51 | 24.51 | 24.51 | 24.51 | 1.96 | |
Total Share Capital | 24.51 | 24.51 | 24.51 | 24.51 | 1.96 | |
Reserves and Surplus | 2,792.87 | 2,307.82 | 2,107.02 | 2,026.31 | 750.79 | |
Total Reserves and Surplus | 2,792.87 | 2,307.82 | 2,107.02 | 2,026.31 | 750.79 | |
Total Shareholders Funds | 2,817.37 | 2,332.32 | 2,138.21 | 2,054.31 | 752.75 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 54.43 | 48.79 | 42.43 | 31.50 | 22.89 | |
Other Long Term Liabilities | 50.96 | 14.76 | 17.09 | 1.20 | 0.00 | |
Long Term Provisions | 18.54 | 15.77 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 123.92 | 79.32 | 59.53 | 32.70 | 22.89 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 390.46 | 368.66 | 396.56 | 307.72 | 221.31 | |
Other Current Liabilities | 62.74 | 58.08 | 92.32 | 61.84 | 980.23 | |
Short Term Provisions | 16.96 | 12.03 | 15.54 | 14.44 | 19.90 | |
Total Current Liabilities | 470.16 | 438.77 | 504.41 | 384.00 | 1,221.44 | |
Total Capital And Liabilities | 3,411.45 | 2,850.41 | 2,702.15 | 2,471.01 | 1,997.08 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 942.67 | 795.01 | 774.89 | 584.65 | 564.89 | |
Intangible Assets | 12.28 | 10.05 | 5.74 | 10.38 | 7.91 | |
Capital Work-In-Progress | 94.25 | 101.19 | 49.35 | 91.69 | 14.10 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 1,056.86 | 911.05 | 842.25 | 686.72 | 586.90 | |
Non-Current Investments | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 19.36 | 23.29 | 9.49 | 19.63 | 11.06 | |
Total Non-Current Assets | 1,076.30 | 934.41 | 851.81 | 706.42 | 598.03 | |
CURRENT ASSETS | ||||||
Current Investments | 477.62 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 673.95 | 666.59 | 604.17 | 516.24 | 513.42 | |
Trade Receivables | 969.74 | 765.43 | 806.77 | 673.49 | 619.50 | |
Cash And Cash Equivalents | 71.24 | 301.59 | 309.40 | 512.16 | 115.60 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 142.62 | 182.38 | 130.01 | 62.69 | 150.52 | |
Total Current Assets | 2,335.16 | 1,916.00 | 1,850.34 | 1,764.58 | 1,399.04 | |
Total Assets | 3,411.45 | 2,850.41 | 2,702.15 | 2,471.01 | 1,997.08 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 37.92 | 34.20 | 12.83 | 50.42 | 17.23 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 491.59 | 468.18 | 500.12 | 1,056.78 | 787.01 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 1,152.18 | 1,035.14 | 969.07 | 388.26 | 395.51 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 19.60 | 19.60 | 19.60 | 19.60 | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | 477.62 | -- | -- | -- | -- |
05.08.2025
Alivus Life Standalone June 2025 Net Sales at Rs 601.85 crore, up 2.25% Y-o-Y
25.10.2024
Glenmark Life Standalone September 2024 Net Sales at Rs 506.88 crore, down 14.86% Y-o-Y
26.07.2024
Glenmark Life Standalone June 2024 Net Sales at Rs 588.62 crore, up 1.76% Y-o-Y
26.04.2024
Glenmark Life Standalone March 2024 Net Sales at Rs 536.60 crore, down 13.64% Y-o-Y